Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Uterine Cervical Neoplasms × Pharmaceutical Preparations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Lymphoma, B-Cell, Marginal Zone 1 Locally Advanced Bladder Cancer 1

Interventions

Cisplatin 53 Paclitaxel 27 Carboplatin 22 Brachytherapy 18 Radiotherapy 17 human papillomavirus vaccine, L1 type 16, 18 12 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 12 Gemcitabine 12 Topotecan 8 Vaccines, Synthetic 7 Platinum 7 Papillomavirus Vaccines 7 Radiation 6 Bevacizumab 6 1,2-diaminocyclohexaneplatinum II citrate 6 Neoadjuvant Therapy 5 Chemotherapy, Adjuvant 5 pembrolizumab 4 Vinorelbine 4 Radiotherapy, Intensity-Modulated 4 Pemetrexed 4 Drug Therapy 4 Taxes 3 Surgical Procedures, Operative 3 Ondansetron 3 Irinotecan 3 Dexamethasone 3 Chemoradiotherapy 3 tisotumab vedotin 2 specific substance maruyama 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02036164 2017-04-06

ACT-LACC

Navamindradhiraj University

Phase 3 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡